News
To no great surprise, the U.K.’s health technology assessment body has found that the benefits of the first two approved ...
Bill Gates is speaking out about his personal experience with Alzheimer’s — and his hope for progress in fighting the disease ...
A newly approved Alzheimer’s drug is set to be administered for the first time in Taiwan on Monday, Far Eastern Memorial Hospital in New Taipei City announced yesterday. Kisunla, the brand name of the ...
In a first for the bloc, Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing ...
And other biotech news brought to you by The Readout.
NEW YORK – The UK's National Institute for Health and Care Excellence on Thursday issued two final guidances, in which it recommended against making Eisai and Biogen's Leqembi (lecanemab) and Eli ...
The 58-year-old had been sharing his expertise in house renovations when the symptoms began to manifest ...
LLY's blockbuster obesity drugs fuel rapid growth but ABBV's valuation and pipeline may offer safer short-term upside.
Note that some links may require registration or subscription. Three people died and 16 have been hospitalized in a listeria ...
Jim Rogers, 58, was living and working in Australia when he started to develop symptoms of the incurable neurological ...
Eli Lilly (NYSE:LLY) announced it would appeal a decision by the U.K. health authorities not to recommend the company’s new ...
Microsoft co-founder Bill Gates reflects on his father's Alzheimer's battle and expresses optimism about advancements in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results